Your browser doesn't support javascript.
loading
Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma.
Ito, Keiichi; Masunaga, Ayako; Tanaka, Nobuyuki; Mizuno, Ryuichi; Shirotake, Suguru; Yasumizu, Yota; Ito, Yujiro; Miyazaki, Yasumasa; Hagiwara, Masayuki; Kanao, Kent; Mikami, Shuji; Momma, Tetsuo; Masuda, Takeshi; Nakagawa, Ken; Oyama, Masafumi; Asano, Tomohiko; Oya, Mototsugu.
Afiliación
  • Ito K; Department of Urology, National Defense Medical College, Saitama, Japan.
  • Masunaga A; Department of Urology, National Defense Medical College, Saitama, Japan.
  • Tanaka N; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Mizuno R; Department of Urology, Saitama City Hospital, Saitama, Japan.
  • Shirotake S; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Yasumizu Y; Department of Urology, Uro-Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Ito Y; Department of Urology, Uro-Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Miyazaki Y; Department of Urology, Saiseikai Central Hospital, Tokyo, Japan.
  • Hagiwara M; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Kanao K; Department of Urology, Ichikawa General Hospital, Tokyo Dental College, Ichikawa, Chiba, Japan.
  • Mikami S; Department of Urology, Keio University School of Medicine, Tokyo, Japan.
  • Momma T; Division of Diagnostic Pathology, Keio University Hospital, Tokyo, Japan.
  • Masuda T; Department of Urology, National Hospital Organization Saitama Hospital, Saitama, Japan.
  • Nakagawa K; Department of Urology, Saitama City Hospital, Saitama, Japan.
  • Oyama M; Department of Urology, Ichikawa General Hospital, Tokyo Dental College, Ichikawa, Chiba, Japan.
  • Asano T; Department of Urology, Uro-Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Oya M; Department of Urology, National Defense Medical College, Saitama, Japan.
Jpn J Clin Oncol ; 49(1): 69-76, 2019 Jan 01.
Article en En | MEDLINE | ID: mdl-30407543
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos / Carcinoma de Células Renales / Biomarcadores / Mediadores de Inflamación / Recuento de Leucocitos / Neutrófilos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Jpn J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfocitos / Carcinoma de Células Renales / Biomarcadores / Mediadores de Inflamación / Recuento de Leucocitos / Neutrófilos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Jpn J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Japón